A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients With Myelofibrosis

By
Jamie Kang
-
0
72
Researchers conducted an investigator-initiated, multicenter, Phase Ib trial of AVID200 monotherapy in 21 advanced myelofibrosis patients.
[Clinical Cancer Research]
Abstract